Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Author Archives: Walter Armstrong
Judge Throws The Book At Former Bristol-Myers Squibb Exec
Media wordsmiths are competing to outdo one another today in punny reporting on the news that ex-BMS exec Andrew Bodnar has been sentenced to write a book about the role he played in the firm’s 2006 reverse-payments case over generic Plavix.
“Pen-ance: Bristol-Myers Exec Gets Two Years of Hard Writing,†The Wall Street Journal Law Blog [...]
Latest News from ASCO: Winners, Losers, and Also Rans
Image via Wikipedia
Due to pharma’s voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week’s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida.
Some 4,000 studies [...]
Posted in Events Tagged AstraZeneca, Cancer, Chemotherapy, Clinical trial, Lung cancer, Sanofi-Aventis, United States 1 Comment

When Big Pharma Leaves Town